World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
75
Citations
20475
World Ranking
1498
National Ranking
654

Ian Frank publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Ian Frank sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 216 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Ian Frank D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Frank sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 75 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Ian Frank is affiliated with the University of Pennsylvania in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in Infectious Diseases, Virology, Immunology, Epidemiology, and Emergency Medicine.

Their main research topics focus extensively on HIV and COVID-19, including areas such as HIV Research and Treatment, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, and Immune Cell Function and Interaction.

Ian Frank's recent notable publications include:

  • mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern, 2021, Science
  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women, 2021, New England Journal of Medicine
  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition, 2021, New England Journal of Medicine
  • Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities, 2021, JAMA
  • Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers, 2020, JAMA Internal Medicine

Ian Frank has frequently published in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • SSRN Electronic Journal
  • The Lancet HIV
  • The Journal of Infectious Diseases

The scientist has collaborated regularly with colleagues including:

  • Lawrence Corey
  • Georgia D. Tomaras
  • Lindsey R. Baden
  • M. Juliana McElrath
  • David C. Montefiori

Best Publications

  • Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

    Pablo Tebas;David Stein;Winson W. Tang;Ian Frank

  • Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract

    Emily S. Charlson;Kyle Bittinger;Andrew R. Haas;Ayannah S. Fitzgerald

  • mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.

    Rishi R. Goel;Mark M. Painter;Sokratis A. Apostolidis;Divij Mathew

  • Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections

    Jason M. Brenchley;Mirko Paiardini;Kenneth S. Knox;Kenneth S. Knox;Ava I. Asher

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Raphael J Landovitz;Deborah Donnell;Meredith E Clement;Brett Hanscom

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Impaired interleukin 12 production in human immunodeficiency virus-infected patients.

    J Chehimi;S E Starr;I Frank;A D'Andrea

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Perforin Expression Directly Ex Vivo by HIV-Specific CD8 + T-Cells Is a Correlate of HIV Elite Control

    Adam R. Hersperger;Florencia Pereyra;Martha Nason;Korey R. Demers

  • IL-7 is a potent and proviral strain–specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART

    Feng-Xiang Wang;Yan Xu;Julie Sullivan;Emily Souder

  • Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10

    Unknown

  • Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

    J Chehimi;S E Starr;I Frank;M Rengaraju

  • Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.

    Helen Horton;Evan P. Thomas;Jason A. Stucky;Ian Frank

  • Standardization of cytokine flow cytometry assays

    Holden T Maecker;Aline Rinfret;Patricia D'Souza;Janice Darden

  • A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

    Valerianna Amorosa;Marie Synnestvedt;Robert Gross;Harvey Friedman

  • Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery

    Spyros A. Kalams;Scott D. Parker;Marnie Elizaga;Barbara Metch

  • A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

    I Frank;H M Friedman

  • Pharmacy Refill Adherence Compared with CD4 Count Changes for Monitoring HIV-Infected Adults on Antiretroviral Therapy

    Gregory P Bisson;Robert Gross;Scarlett Bellamy;Jesse Chittams

  • Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial

    Martin Markowitz;Ian Frank;Robert M Grant;Kenneth H Mayer

  • Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration

    Livio Azzoni;Andrea S. Foulkes;Emmanouil Papasavvas;Angela M. Mexas

  • Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.

    G Dubin;E Socolof;I Frank;H M Friedman

  • Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.

    Benjamin S. Abella;Eliana L. Jolkovsky;Barbara T. Biney;Julie E. Uspal

Frequent Co-Authors

Robert E. Gross
Robert E. Gross Emory University
Pablo Tebas
Pablo Tebas University of Pennsylvania
David S. Metzger
David S. Metzger University of Pennsylvania
M. Juliana McElrath
M. Juliana McElrath University of Washington
Peter B. Gilbert
Peter B. Gilbert Fred Hutchinson Cancer Research Center
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Mirko Paiardini
Mirko Paiardini Emory University
Guido Silvestri
Guido Silvestri Emory University
Joseph J. Eron
Joseph J. Eron University of North Carolina at Chapel Hill
Ronald G. Collman
Ronald G. Collman University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Microbiology in the USA, exploring complementary career pathways can open diverse opportunities in healthcare and research. Many graduates find value in adjunct qualifications that enhance their expertise and job prospects.

One such avenue is becoming a Certified Professional Coder. Obtaining a certified professional coder certification equips individuals with essential skills for medical billing and coding, vital to healthcare administration and insurance processes.

Health Information Management is another promising field for microbiology graduates looking to diversify. Earning a degree in this area often leads to competitive salaries and dynamic roles. Detailed insights on earnings and role expectations are available through the health information management degree salary guide.

For those interested in accredited education options, exploring the best online health information management degree cahiim accredited programs provides flexible pathways to obtain recognized qualifications suited for remote learning.

Additionally, accelerated paths such as an accelerated medical billing and coding certificate online offer quick entry into the field, ideal for those aiming to complement their science background with practical administrative skills.

Best Scientists Citing Ian Frank

Trending Scientists

Recently Published Articles